Founded in 2001 in Warsaw, Poland, Synektik S.A. has developed into one of Central Europe’s leading healthcare technology companies, focused on radiopharmaceuticals, advanced medical equipment, diagnostic imaging IT, and robotic surgery solutions. Headquartered in Warsaw and listed on the Warsaw Stock Exchange, the company is the Polish leader in the production and distribution of radiopharmaceuticals for PET/CT diagnostics and has built a broad platform spanning imaging diagnostics, nuclear medicine, servicing, research and development, and proprietary telemedicine and radiology software. Synektik is also the exclusive distributor of da Vinci robotic surgical systems in Poland, the Czech Republic, Slovakia, and the Baltic states. In the financial year ended September 30, 2025, the group reported sales of PLN 682 million, reflecting the scale and growing relevance of a business that brings advanced medical technologies to the healthcare sector across the region.
Updated 2026-03-19